Articles

Encouraging signs in the quest against Alzheimer’s

30th July 2014

Encouraging signs in the quest against Alzheimer’sJan Lundberg, PhD

Collaboration among experts in Alzheimer's research is aiding progress towards the goals of specific diagnostics for various types of dementia, combined with safe and effective medicines.There were glimmers of hope... Read more

Genomics – the gateway to personalised medicine

29th July 2014

Genomics – the gateway to personalised medicineSarah Holme

Since the completion of the human genome project in 2003, a world of possibilities has been opened up for the personalisation of medicine. From determining predisposition to disease through to... Read more

Who influences NICE technology appraisals?

28th July 2014

Who influences NICE technology appraisals?Leela Barham

In the world of pharmaceuticals everyone seems to have heard of the National Institute for Health and Care Excellence (NICE). That's not only because of its influence on access to... Read more

Clinical trials insight: oncology

25th July 2014

Clinical trials insight: oncologyNick Kenny

INC Research's Dr Nick Kenny talks to pharmaphorum about the challenges of running global clinical trials in the rapidly evolving field of oncology.What are the biggest challenges in planning oncology... Read more

News

Obama goes public on tax inversion loophole

30th July 2014

Obama goes public on tax inversion loophole

President Barack Obama has made a public pledge to close the tax loophole that allows corporations to avoid paying US corporate taxes by taking over companies in other countries.The White... Read more

AstraZeneca and Kyowa Hakko Kirin partner on immuno-oncology

30th July 2014

AstraZeneca and Kyowa Hakko Kirin partner on immuno-oncologyLinda Banks

AstraZeneca(AZ) is to work with Kyowa Hakko Kirin on a phase I/Ib immuno-oncology study that will evaluate two separate combinations of three investigational compounds in multiple solid tumours.The study will... Read more

AstraZeneca to pay up to $2 billion for Almirall respiratory franchise

30th July 2014

AstraZeneca to pay up to $2 billion for Almirall respiratory franchise

AstraZeneca has made a bold move to expand its respiratory franchise by buying up drugs and pipeline candidates from Spanish pharma company Almirall.AstraZeneca will pay the Barcelona-headquartered pharma company $875... Read more

Transmission-blocking vaccines 'could hold key to malaria control'

29th July 2014

Transmission-blocking vaccines 'could hold key to malaria control'Staff reporter

A vaccine that prevents transmission of the malaria parasite from mosquitoes to people could hold the key to effective, population-wide control of the disease, according to researchers.A team from German... Read more

Audio & Video

Webinar: 9 July - The future of UK pharm…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

Rare Disease Day tweetchat

 

To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click View more

Is there common ground for engagement be…

Doctors net webinar

 

The growth of online networks for doctors has been accompanied by recognition from the pharmaceutical industry that these digital meeting grounds can be... View more

Executive Perspectives: Jane Griffiths

 

In the latest in our series of interviews with senior executives who are steering the global pharma industry through a period of unparalleled change, pharmaphorum... View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

High uptake for Novartis’ meningitis B vaccination programme

Novartis' first-in-class meningitis B vaccine Bexsero has seen high uptake for the first regional vaccination pr... Read more

News

Leukaemia drugs move closer to European approval

Two groundbreaking new treatments for chronic lymphocytic leukaemia have been recommended by Europe's CHMP medic... Read more

News

Australian Health Minister's bid to censor CF comments backfires

Australia's Health Minister Peter Dutton may be regretting his decision to remove posts on his Facebook accou... Read more

News

Synthetic biology firm raises $29m

A US company set up to create engineered bacteria that can both detect and treat diseases has raised $29 mill... Read more

News

World Hepatitis Day highlights the positive

The push to raise awareness of hepatitis globally has been boosted by recent debate around Gilead's breakthrough... Read more

News

AstraZeneca to collaborate on DNA diagnostics for cancer

AstraZeneca is to collaborate on two new diagnostics which would allow doctors to screen for lung cancer simp... Read more

News